Skip to main content
Premium Trial:

Request an Annual Quote

Rosetta Genomics to Sell $1.9M in Securities, Inks miRNA Dx Distribution Deal for China


Rosetta Genomics this week announced that it has signed a definitive agreement to sell $1.9 million in stock and warrants in a private placement.

The money comes at a key time for the company, which has been struggling under a cash crunch that led to a restructuring that will include the elimination of more than half its staff (see related story, this issue).

Separately this week, Rosetta said that it has forged a deal giving Avatao Biotech the exclusive rights to market its miRview Mets and miRview Mets 2 microRNA diagnostics, which are used to determine the source of cancers of unknown primary origin, in China.

Under the terms of the private placement, Rosetta will sell roughly 2.6 million ordinary shares at $0.75 each, as well as warrants to purchase an additional 2.6 million shares at $1 each, to private investors. The investors will also receive warrants to buy up to 1.3 million additional shares at an exercise price of $0.01 or NIS 0.04, whichever is greater.

Through the diagnostics deal, Avatao will have the rights to sell the two products in China, as well as Hong Kong, Taiwan, and Macau. Rosetta will receive undisclosed upfront payments, fees upon the achievement of certain regulatory and commercial milestones, and royalties on net sales.

Total payments, including royalties, could exceed $8 million, Rosetta said.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.